Menu
About Us
Overview
Our Team
Our ESG Position
Careers
Services
What We Do
Investor Relations
IPO Readiness
Media Relations
Issues and Crisis Communications
Digital Content & Social Media Activation
Marketing and Brand Campaigns
Video Production
ESG
ESG Competent Boards Masterclass
News & events
Blog
Contact
Contact Us
Email Alerts
IR Department Newsletter - September 2022
News & events
>
Blog
Recent Posts
HealthInvest April 2025 recap: bringing life sciences to the forefront
Upcoming: HealthInvest April 2025
Equity Insights: December Issue
Navigating AGM Season: Insights from Jane Lowe
3 ways new ESG management and auditing standards could affect all Australian listed companies
Archives
April 2025
March 2025
December 2024
November 2024
October 2024
September 2024
August 2024
May 2024
December 2023
October 2023
July 2023
March 2023
February 2023
November 2022
October 2022
September 2022
August 2022
July 2022
March 2022
February 2022
Categories
AGMs
Crisis communications
Equity Insights
ESG
Investor relations
Newsletter March 2022
Newsletter Sept 2022
Uncategorized
IR Department Newsletter – September 2022
August 31st, 2022
IR Department client media highlights
Read More
August 31st, 2022
Interview with Peter Devine, CEO of Uniseed
Read More
August 29th, 2022
XPON CEO Matt Forman discusses Wondaris and how it integrates with Google
Read More
August 29th, 2022
Kazia Therapeutics CEO Dr James Garner talks with SmallCaps about what's on the horizon
Read More
August 29th, 2022
Interview with Assoc.Prof. Mathias Francois of Gertrude Biomedical
Read More
August 29th, 2022
HaemaLogiX's Tertia Dex explains the KappaMab antibody
Read More
August 29th, 2022
Race Oncology CSO Dr Daniel Tillett discusses the bright future for Zantrene
Read More
August 29th, 2022
Mosquito-borne diseases in Australia - an interview with Dr David Foster, CEO of Island Pharmaceuticals
Read More
July 4th, 2022
Podcast - IR Department talks with AdAlta CEO & MD, Dr Tim Oldham
Read More
1